vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and GLOBAL INDUSTRIAL Co (GIC). Click either name above to swap in a different company.
GLOBAL INDUSTRIAL Co is the larger business by last-quarter revenue ($345.6M vs $284.0M, roughly 1.2× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 4.2%, a 92.1% gap on every dollar of revenue. On growth, GLOBAL INDUSTRIAL Co posted the faster year-over-year revenue change (14.3% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 3.4%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Global Industrial Company is a Port Washington, New York–based company providing industrial and MRO products through a system of branded e-Commerce websites and relationship marketers in North America. The primary brand is Global Industrial.
ACAD vs GIC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $345.6M |
| Net Profit | $273.6M | $14.6M |
| Gross Margin | 90.8% | 34.5% |
| Operating Margin | 6.1% | 5.7% |
| Net Margin | 96.3% | 4.2% |
| Revenue YoY | 9.4% | 14.3% |
| Net Profit YoY | 90.3% | 36.4% |
| EPS (diluted) | $1.61 | $0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $345.6M | ||
| Q3 25 | $278.6M | $353.6M | ||
| Q2 25 | $264.6M | $358.9M | ||
| Q1 25 | $244.3M | $321.0M | ||
| Q4 24 | $259.6M | $302.3M | ||
| Q3 24 | $250.4M | $342.4M | ||
| Q2 24 | $242.0M | $347.8M | ||
| Q1 24 | $205.8M | $323.4M |
| Q4 25 | $273.6M | $14.6M | ||
| Q3 25 | $71.8M | $18.8M | ||
| Q2 25 | $26.7M | $25.1M | ||
| Q1 25 | $19.0M | $13.6M | ||
| Q4 24 | $143.7M | $10.7M | ||
| Q3 24 | $32.8M | $16.8M | ||
| Q2 24 | $33.4M | $20.3M | ||
| Q1 24 | $16.6M | $13.2M |
| Q4 25 | 90.8% | 34.5% | ||
| Q3 25 | 92.2% | 35.6% | ||
| Q2 25 | 92.2% | 37.1% | ||
| Q1 25 | 91.7% | 34.9% | ||
| Q4 24 | 91.6% | 33.8% | ||
| Q3 24 | 92.5% | 34.0% | ||
| Q2 24 | 92.5% | 35.2% | ||
| Q1 24 | 88.8% | 34.3% |
| Q4 25 | 6.1% | 5.7% | ||
| Q3 25 | 12.8% | 7.4% | ||
| Q2 25 | 12.2% | 9.3% | ||
| Q1 25 | 7.9% | 5.7% | ||
| Q4 24 | 59.1% | 4.8% | ||
| Q3 24 | 12.6% | 6.5% | ||
| Q2 24 | 12.6% | 7.6% | ||
| Q1 24 | 7.4% | 5.4% |
| Q4 25 | 96.3% | 4.2% | ||
| Q3 25 | 25.8% | 5.3% | ||
| Q2 25 | 10.1% | 7.0% | ||
| Q1 25 | 7.8% | 4.2% | ||
| Q4 24 | 55.4% | 3.5% | ||
| Q3 24 | 13.1% | 4.9% | ||
| Q2 24 | 13.8% | 5.8% | ||
| Q1 24 | 8.0% | 4.1% |
| Q4 25 | $1.61 | $0.37 | ||
| Q3 25 | $0.42 | $0.48 | ||
| Q2 25 | $0.16 | $0.65 | ||
| Q1 25 | $0.11 | $0.35 | ||
| Q4 24 | $0.86 | $0.28 | ||
| Q3 24 | $0.20 | $0.44 | ||
| Q2 24 | $0.20 | $0.52 | ||
| Q1 24 | $0.10 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $67.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $313.2M |
| Total Assets | $1.6B | $580.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $67.5M | ||
| Q3 25 | $258.0M | $67.2M | ||
| Q2 25 | $253.6M | $55.1M | ||
| Q1 25 | $217.7M | $39.0M | ||
| Q4 24 | $319.6M | $44.6M | ||
| Q3 24 | $155.1M | $38.9M | ||
| Q2 24 | $177.1M | $38.8M | ||
| Q1 24 | $204.7M | $29.9M |
| Q4 25 | $1.2B | $313.2M | ||
| Q3 25 | $917.3M | $316.0M | ||
| Q2 25 | $822.4M | $305.2M | ||
| Q1 25 | $765.2M | $287.9M | ||
| Q4 24 | $732.8M | $281.1M | ||
| Q3 24 | $577.2M | $279.2M | ||
| Q2 24 | $516.7M | $270.4M | ||
| Q1 24 | $464.0M | $260.2M |
| Q4 25 | $1.6B | $580.8M | ||
| Q3 25 | $1.3B | $602.5M | ||
| Q2 25 | $1.2B | $586.5M | ||
| Q1 25 | $1.1B | $536.7M | ||
| Q4 24 | $1.2B | $520.7M | ||
| Q3 24 | $976.9M | $531.6M | ||
| Q2 24 | $914.1M | $542.5M | ||
| Q1 24 | $855.1M | $517.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $20.0M |
| Free Cash FlowOCF − Capex | — | $19.2M |
| FCF MarginFCF / Revenue | — | 5.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | -0.18× | 1.37× |
| TTM Free Cash FlowTrailing 4 quarters | — | $74.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $20.0M | ||
| Q3 25 | $74.3M | $22.7M | ||
| Q2 25 | $64.0M | $31.7M | ||
| Q1 25 | $20.3M | $3.4M | ||
| Q4 24 | $40.4M | $15.9M | ||
| Q3 24 | $63.2M | $9.6M | ||
| Q2 24 | $25.0M | $18.8M | ||
| Q1 24 | $29.1M | $6.4M |
| Q4 25 | — | $19.2M | ||
| Q3 25 | $73.9M | $22.0M | ||
| Q2 25 | — | $30.3M | ||
| Q1 25 | — | $3.2M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | $63.2M | $8.7M | ||
| Q2 24 | — | $17.9M | ||
| Q1 24 | — | $5.1M |
| Q4 25 | — | 5.6% | ||
| Q3 25 | 26.5% | 6.2% | ||
| Q2 25 | — | 8.4% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | 25.2% | 2.5% | ||
| Q2 24 | — | 5.1% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | 0.1% | 0.2% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.4% |
| Q4 25 | -0.18× | 1.37× | ||
| Q3 25 | 1.03× | 1.21× | ||
| Q2 25 | 2.40× | 1.26× | ||
| Q1 25 | 1.07× | 0.25× | ||
| Q4 24 | 0.28× | 1.49× | ||
| Q3 24 | 1.93× | 0.57× | ||
| Q2 24 | 0.75× | 0.93× | ||
| Q1 24 | 1.76× | 0.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
GIC
Segment breakdown not available.
